We are an iconic provider of hospital-based healthcare, striving to deliver an exceptional standard of care
We comprise several hospitals, health centres, a nationally accredited education provider and a world-class research institute
We are a nationally accredited, hospital-based Registered Training Organisation - the only one of its kind in Queensland
We are part of a collaborative research institute with The University of Queensland and founding partner of the Translational Research Institute
A Queensland-first trial that will assess the impacts of COVID-19 on expectant parents and their unborn babies is being carried out at Mater Mothers’ Hospitals, supported by a $500 000 donation from the Lott, via Golden Casket.
Forming part of the Queensland Family Cohort Study which is already underway, a research team at Mater are in the process of recruiting 300 families who have endured the stress brought on by the COVID-19 crisis, while being pregnant.
Mater Research Professor Vicki Clifton said it was important to capture data from both expectant mothers and fathers during this once-in-a-lifetime pandemic to see what the impacts of the crisis were on families, the pregnancy and their babies as they developed.
“We know from previous research undertaken at Mater on the impacts of the 2011 floods that you don’t need to be directly affected by a crisis to have increased stress hormones in your system.
“We know from this study that this affects the placenta and there is a change in the developmental profiles of the baby.
“Many families we have recruited during the pandemic are experiencing stress, whether that’s financial strain due to losing their jobs, or emotional stress, as they are uncertain about the future.
“It’s important that while we have, and continue to experience a pandemic, that we are evaluating the impacts on these families and also how this will influence their babies’ development up until they are school age,” Professor Clifton said.
The Queensland Family Cohort Study pilot began in 2018 with the aim to address disease at its core and determine how a baby’s health and exposure in early life influences the onset of disease in the future.
To achieve this, Professor Clifton’s team assess the physical and mental health of families and collect biological information from samples throughout pregnancy and at birth.
Professor Clifton said the data collected from the families impacted by COVID-19 would be compared to those recruited prior to the pandemic.
“Comparing data across both cohorts gives us a clearer picture of the true impact of the pandemic.
“We already know from data captured prior to COVID that some parents often have a high level of anxiety and depression for a number of reasons, so we want to know how the pandemic adds to the stress that families generally experience.
“We hope the data captured helps to change clinical practice as well as social support for families in the future where we can better identify kids at risk and provide them the support they need, especially before they start school.”
Now 28 weeks, Claudia Hoch is expecting her second baby boy at Mater Mothers' Private Brisbane in September.
She signed up to the study, realising the importance of collecting data during her pregnancy, in particular during a pandemic situation.
“This pregnancy has been very different to my first as I’ve experienced more anxiety due to COVID-19,” she said.
“I know they say that pregnant women have a low risk of catching the virus, however you don’t want to take any risks.
“I wasn’t sure if I should send my son to daycare or not. It’s been an unsettling time for us all.”
Mrs Hoch said with her background in public health, the Family Cohort Study was an important research project to be involved in.
“Looking at the environment of both parents during pregnancy and how this may impact their unborn child is an interesting concept that needs exploring, in particular through a pandemic as we just don’t know what the impacts are on the unborn child and their development,” she said.
The team are also looking to recruit an additional 100 families from an Indigenous background to take part in the study.
Professor Clifton thanked Golden Casket for its support of the project and many other important studies currently underway at Mater.
"It’s support like this from Golden Casket that allows us to pursue this necessary research which has the capability of improving outcomes for families across the country,” she said.
Families interested in taking part in the study and who are birthing at Mater Mothers’ Hospitals can email email@example.com.
07 3163 1524
07 3163 6142
Rosie Stoke has won The University of Queensland’s 2021 Three Minute Thesis (3MT) Competition and will go on to the Asia-Pacific 3MT Competition next month.
In the last decade an increasing number of Australian patients have been diagnosed with autoimmune associated epilepsy.
The future of Intensive Care medicine in Australia
It is estimated over 110 000 people are living with blood cancer or a related blood disorder in Australia today and sadly 15 people lose their life to blood cancer ...